查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1566778

基因組學市場：按產品、技術、應用和最終用戶分類：2024-2033 年全球機會分析和產業預測

Genomics Market By Product , By Technology By Application By End User : Global Opportunity Analysis and Industry Forecast, 2024-2033
出版日期: | 出版商: Allied Market Research | 英文 280 Pages | 商品交期: 2-3個工作天內

價格
簡介目錄

基因組市場

2023年基因組學市場價值為332億美元，預計2024年至2033年複合年成長率為11.5%，到2033年達到971億美元。

基因組學是分子生物學的一部分，是研究生物基因組的結構、功能、繪圖、演化和編輯。基因組被定義為個體的整個去氧核糖核酸（DNA）。 DNA 是生物體內的重要化合物，包含對其發育和功能很重要的資訊。基因組學的主要作用是確定構成生物體 DNA 的分子序列。

透過個人化治療計劃、疾病診斷和基因檢測，基因組學日益融入醫療保健領域，推動了市場開拓。開發新藥的不斷努力也推動了對創新基因組學技術的需求。最近的趨勢包括 3D/空間基因組學，它研究細胞核內染色質的空間關係。這項技術預計將徹底改變人類健康和醫療領域，因為它提供了對個人基因組成的新見解。

然而，建立基因組實驗室和開發基礎設施所需的巨額成本限制了市場的成長。此外，與濫用遺傳資料相關的高風險限制了市場開拓。根據國家生物技術資訊中心的報導，每年有數百萬人動態地向各種機構提供無限量的健康資訊以供多種用途，包括保險和商業。資料共用如此普遍，以至於 HIPPA（健康保險互通性與課責法案）和 HIPAA 隱私條例所涵蓋的實體無法獲得資訊，從而失去了所提供的安全性。

按部門審查

基因組學市場分為產品、技術、應用、最終用戶和地區。依產品分為消耗品/試劑、服務、設備、系統及軟體。依技術分為定序、PCR、流式細胞技術、微陣列等。依應用分類，可分為功能基因體學、表觀基因、路徑分析、生物標記發現等。最終用戶分為臨床研究、學術/政府機構、醫院/診所、製藥/生技公司等。從區域來看，分析包括北美、歐洲、亞太地區和拉丁美洲/中東/非洲。

主要發現

按產品分類，消耗品和試劑細分市場將在 2023 年佔據主導地位。

依技術分類，定序市場在 2023 年佔據最高市場佔有率。

從應用來看，功能基因體學領域在 2023 年佔據了較高的市場。

從最終用戶來看，製藥和生技公司將在 2023 年成為最大股東。

按地區分類，北美地區 2023 年收益最高。

可使用此報告進行客製化（需要額外費用和時間表）

  • 根據客戶興趣加入公司簡介
  • 按國家或地區進行的附加分析 – 市場規模和預測
  • 平均售價分析/價位分析
  • 十字交叉細分市場分析—市場規模與預測
  • 擴大公司簡介列表
  • 歷史市場資料
  • 主要參與企業的詳細資料（Excel格式，包括位置、聯絡資訊、供應商/供應商網路等）
  • 全球/區域/國家層級參與企業的市場佔有率分析

目錄

第1章簡介

第 2 章執行摘要

第3章 市場狀況

  • 市場定義和範圍
  • 主要發現
    • 關鍵投資機會
    • 關鍵成功策略
  • 波特五力分析
  • 市場動態
    • 促進因素
    • 抑制因素
    • 機會

第4章基因組學市場：依產品

  • 市場概況
  • 耗材/試劑
  • 服務
  • 設備、系統、軟體

第5章基因組學市場：依技術分類

  • 市場概況
  • 定序
  • PCR法
  • 流式細胞技術
  • 微陣列
  • 其他

第6章 基因組學市場：依應用分類

  • 市場概況
  • 功能基因體學
  • 表觀基因
  • 通路分析
  • 生物標記搜尋
  • 其他

第7章 基因組學市場：依最終使用者分類

  • 市場概況
  • 臨床研究所
  • 學術/政府
  • 醫院/診所
  • 製藥和生物技術公司
  • 其他

第8章基因組學市場：按地區

  • 市場概況
  • 北美洲
    • 主要市場趨勢和機遇
    • 美國基因組市場
    • 加拿大基因組市場
    • 墨西哥基因組市場
  • 歐洲
    • 主要市場趨勢和機遇
    • 法國基因組市場
    • 德國基因組市場
    • 義大利基因組市場
    • 西班牙基因組市場
    • 英國基因組學市場
    • 其他歐洲基因組市場
  • 亞太地區
    • 主要市場趨勢和機遇
    • 中國基因組市場
    • 日本基因組學市場
    • 印度基因組市場
    • 韓國基因組學市場
    • 澳洲基因組市場
    • 其他亞太基因組學市場
  • 拉丁美洲/中東/非洲
    • 主要市場趨勢和機遇
    • 巴西基因組市場
    • 南非基因組市場
    • 沙烏地阿拉伯基因組市場
    • 阿拉伯聯合大公國基因組市場
    • 其他拉丁美洲/中東/非洲基因組學市場

第9章 競爭格局

  • 介紹
  • 關鍵成功策略
  • 10家主要企業產品圖譜
  • 競爭對手儀表板
  • 競爭熱圖
  • 主要企業定位（2023年）

第10章 公司簡介

  • Color Genomics, Inc.
  • BGI Genomics
  • Agilent Technologies
  • Danaher Corporation
  • Eppendorf AG
  • Eurofins Scientific SE
  • F. Hoffmann-La Roche Ltd.
  • GE Healthcare
  • Illumina, Inc.
  • Bio-Rad Laboratories, Inc.
簡介目錄
Product Code: A05109

Genomics Market

The genomics market was valued at $33.2 billion in 2023 and is projected to reach $97.1 billion by 2033, growing at a CAGR of 11.5% from 2024 to 2033.

Genomics is the branch of molecular biology that involves the study of structure, function, mapping, evolution, and editing of the genome of living organisms. A genome is defined as the entire set of an individual's deoxyribonucleic acid (DNA). DNA is an essential chemical compound present inside a living body that contains the critical information for the development and functioning of the body. The major role of genomics is to determine the sequence of molecules which form the DNA content of organisms.

Increase in the integration of genomics into healthcare through personalized treatment plans, diagnosis of diseases, and genetic testing is driving the development of the market. In addition, constant efforts toward new drug development are boosting the demand for innovative genomics technology. In recent times, 3D and spatial genomics is a flourishing trend that involves studying the spatial positioning of chromatin inside the nucleus. This technology is predicted to revolutionize the field of human health and medicine owing to the novel insights it provides into the genetic makeup of individuals.

However, the high expense of establishing genomics laboratories and infrastructure acts as a key restraint for the growth of the market. In addition, the high risk associated with the misuse of genetic data limits market development. According to an article by the National Center for Biotechnology Information, every year millions of individuals dynamically provide unlimited access of their health information to different institutions for multiple uses, including insurance and commercial transactions. The sharing of data is highly extensive such that the information becomes available to institutions not covered under Health Insurance Portability and Accountability Act (HIPPA), thereby losing the security offered by the HIPAA Privacy Rule.

Segment Review

The genomics market is segmented into product, technology, application, end user, and region. On the basis of product, the market is divided into consumables & reagent, services, instruments, systems and software. By technology, it is classified into sequencing, PCR, flow cytometry, microarray, and others. As per application, it is categorized into functional genomics, epigenomics, pathway analysis, biomarker discovery, and others. Depending on end user, it is segmented into clinical research, academic & government institutions, hospitals & clinics, pharmaceutical & biotechnology companies, and others. Region wise, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

Key Findings

On the basis of product, the consumables & reagent segment dominated the market in 2023.

By technology, the sequencing segment held the highest market share in 2023.

As per application, the functional genomics segment acquired a high stake in the market in 2023.

Depending on end user, the pharmaceutical & biotechnology companies segment was the highest shareholder in 2023.

Region wise, North America was the highest revenue generator in 2023.

Competition Analysis

The leading players operating in the global genomics market include Color Genomics, Inc., BGI Genomics, Agilent Technologies, Danaher Corporation, Eppendorf AG, Eurofins Scientific SE, F. Hoffmann-La Roche Ltd., GE Healthcare, Illumina, Inc., and Bio-Rad Laboratories, Inc. These major players have adopted various key development strategies such as business expansion, new product launches, and partnerships, to strengthen their foothold in the competitive market.

Additional benefits you will get with this purchase are:

  • Quarterly Update and* (only available with a corporate license, on listed price)
  • 5 additional Company Profile of client Choice pre- or Post-purchase, as a free update.
  • Free Upcoming Version on the Purchase of Five and Enterprise User License.
  • 16 analyst hours of support* (post-purchase, if you find additional data requirements upon review of the report, you may receive support amounting to 16 analyst hours to solve questions, and post-sale queries)
  • 15% Free Customization* (in case the scope or segment of the report does not match your requirements, 15% is equivalent to 3 working days of free work, applicable once)
  • Free data Pack on the Five and Enterprise User License. (Excel version of the report)
  • Free Updated report if the report is 6-12 months old or older.
  • 24-hour priority response*
  • Free Industry updates and white papers.

Possible Customization with this report (with additional cost and timeline, please talk to the sales executive to know more)

  • Additional company profiles with specific to client's interest
  • Additional country or region analysis- market size and forecast
  • Average Selling Price Analysis / Price Point Analysis
  • Criss-cross segment analysis- market size and forecast
  • Expanded list for Company Profiles
  • Historic market data
  • Key player details (including location, contact details, supplier/vendor network etc. in excel format)
  • Market share analysis of players at global/region/country level

Key Market Segments

By Product

  • Consumables and Reagent
  • Services
  • Instruments, Systems and Software

By Technology

  • Sequencing
  • PCR
  • Flow Cytometry
  • Microarray
  • Others

By Application

  • Functional Genomics
  • Epigenomics
  • Pathway Analysis
  • Biomarker Discovery
  • Others

By End User

  • Clinical Research
  • Academic and Government Institutions
  • Hospitals and Clinics
  • Pharmaceutical and Biotechnology Companies
  • Others

By Region

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • France
    • Germany
    • Italy
    • Spain
    • UK
    • Rest of Europe
  • Asia-Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Rest of Asia-Pacific
  • LAMEA
    • Brazil
    • South Africa
    • Saudi Arabia
    • UAE
    • Rest of LAMEA

Key Market Players:

    • Color Genomics, Inc.
    • BGI Genomics
    • Agilent Technologies
    • Danaher Corporation
    • Eppendorf AG
    • Eurofins Scientific SE
    • F. Hoffmann-La Roche Ltd.
    • GE Healthcare
    • Illumina, Inc.
    • Bio-Rad Laboratories, Inc.

TABLE OF CONTENTS

CHAPTER 1: INTRODUCTION

  • 1.1. Report Description
  • 1.2. Key Market Segments
  • 1.3. Key Benefits
  • 1.4. Research Methodology
    • 1.4.1. Primary Research
    • 1.4.2. Secondary Research
    • 1.4.3. Analyst Tools and Models

CHAPTER 2: EXECUTIVE SUMMARY

  • 2.1. CXO Perspective

CHAPTER 3: MARKET LANDSCAPE

  • 3.1. Market Definition and Scope
  • 3.2. Key Findings
    • 3.2.1. Top Investment Pockets
    • 3.2.2. Top Winning Strategies
  • 3.3. Porter's Five Forces Analysis
    • 3.3.1. Bargaining Power of Suppliers
    • 3.3.2. Threat of New Entrants
    • 3.3.3. Threat of Substitutes
    • 3.3.4. Competitive Rivalry
    • 3.3.5. Bargaining Power among Buyers
  • 3.4. Market Dynamics
    • 3.4.1. Drivers
    • 3.4.2. Restraints
    • 3.4.3. Opportunities

CHAPTER 4: GENOMICS MARKET, BY PRODUCT

  • 4.1. Market Overview
    • 4.1.1 Market Size and Forecast, By Product
  • 4.2. Consumables And Reagent
    • 4.2.1. Key Market Trends, Growth Factors and Opportunities
    • 4.2.2. Market Size and Forecast, By Region
    • 4.2.3. Market Share Analysis, By Country
  • 4.3. Services
    • 4.3.1. Key Market Trends, Growth Factors and Opportunities
    • 4.3.2. Market Size and Forecast, By Region
    • 4.3.3. Market Share Analysis, By Country
  • 4.4. Instruments, Systems And Software
    • 4.4.1. Key Market Trends, Growth Factors and Opportunities
    • 4.4.2. Market Size and Forecast, By Region
    • 4.4.3. Market Share Analysis, By Country

CHAPTER 5: GENOMICS MARKET, BY TECHNOLOGY

  • 5.1. Market Overview
    • 5.1.1 Market Size and Forecast, By Technology
  • 5.2. Sequencing
    • 5.2.1. Key Market Trends, Growth Factors and Opportunities
    • 5.2.2. Market Size and Forecast, By Region
    • 5.2.3. Market Share Analysis, By Country
  • 5.3. PCR
    • 5.3.1. Key Market Trends, Growth Factors and Opportunities
    • 5.3.2. Market Size and Forecast, By Region
    • 5.3.3. Market Share Analysis, By Country
  • 5.4. Flow Cytometry
    • 5.4.1. Key Market Trends, Growth Factors and Opportunities
    • 5.4.2. Market Size and Forecast, By Region
    • 5.4.3. Market Share Analysis, By Country
  • 5.5. Microarray
    • 5.5.1. Key Market Trends, Growth Factors and Opportunities
    • 5.5.2. Market Size and Forecast, By Region
    • 5.5.3. Market Share Analysis, By Country
  • 5.6. Others
    • 5.6.1. Key Market Trends, Growth Factors and Opportunities
    • 5.6.2. Market Size and Forecast, By Region
    • 5.6.3. Market Share Analysis, By Country

CHAPTER 6: GENOMICS MARKET, BY APPLICATION

  • 6.1. Market Overview
    • 6.1.1 Market Size and Forecast, By Application
  • 6.2. Functional Genomics
    • 6.2.1. Key Market Trends, Growth Factors and Opportunities
    • 6.2.2. Market Size and Forecast, By Region
    • 6.2.3. Market Share Analysis, By Country
  • 6.3. Epigenomics
    • 6.3.1. Key Market Trends, Growth Factors and Opportunities
    • 6.3.2. Market Size and Forecast, By Region
    • 6.3.3. Market Share Analysis, By Country
  • 6.4. Pathway Analysis
    • 6.4.1. Key Market Trends, Growth Factors and Opportunities
    • 6.4.2. Market Size and Forecast, By Region
    • 6.4.3. Market Share Analysis, By Country
  • 6.5. Biomarker Discovery
    • 6.5.1. Key Market Trends, Growth Factors and Opportunities
    • 6.5.2. Market Size and Forecast, By Region
    • 6.5.3. Market Share Analysis, By Country
  • 6.6. Others
    • 6.6.1. Key Market Trends, Growth Factors and Opportunities
    • 6.6.2. Market Size and Forecast, By Region
    • 6.6.3. Market Share Analysis, By Country

CHAPTER 7: GENOMICS MARKET, BY END USER

  • 7.1. Market Overview
    • 7.1.1 Market Size and Forecast, By End User
  • 7.2. Clinical Research
    • 7.2.1. Key Market Trends, Growth Factors and Opportunities
    • 7.2.2. Market Size and Forecast, By Region
    • 7.2.3. Market Share Analysis, By Country
  • 7.3. Academic And Government Institutions
    • 7.3.1. Key Market Trends, Growth Factors and Opportunities
    • 7.3.2. Market Size and Forecast, By Region
    • 7.3.3. Market Share Analysis, By Country
  • 7.4. Hospitals And Clinics
    • 7.4.1. Key Market Trends, Growth Factors and Opportunities
    • 7.4.2. Market Size and Forecast, By Region
    • 7.4.3. Market Share Analysis, By Country
  • 7.5. Pharmaceutical And Biotechnology Companies
    • 7.5.1. Key Market Trends, Growth Factors and Opportunities
    • 7.5.2. Market Size and Forecast, By Region
    • 7.5.3. Market Share Analysis, By Country
  • 7.6. Others
    • 7.6.1. Key Market Trends, Growth Factors and Opportunities
    • 7.6.2. Market Size and Forecast, By Region
    • 7.6.3. Market Share Analysis, By Country

CHAPTER 8: GENOMICS MARKET, BY REGION

  • 8.1. Market Overview
    • 8.1.1 Market Size and Forecast, By Region
  • 8.2. North America
    • 8.2.1. Key Market Trends and Opportunities
    • 8.2.2. Market Size and Forecast, By Product
    • 8.2.3. Market Size and Forecast, By Technology
    • 8.2.4. Market Size and Forecast, By Application
    • 8.2.5. Market Size and Forecast, By End User
    • 8.2.6. Market Size and Forecast, By Country
    • 8.2.7. U.S. Genomics Market
      • 8.2.7.1. Market Size and Forecast, By Product
      • 8.2.7.2. Market Size and Forecast, By Technology
      • 8.2.7.3. Market Size and Forecast, By Application
      • 8.2.7.4. Market Size and Forecast, By End User
    • 8.2.8. Canada Genomics Market
      • 8.2.8.1. Market Size and Forecast, By Product
      • 8.2.8.2. Market Size and Forecast, By Technology
      • 8.2.8.3. Market Size and Forecast, By Application
      • 8.2.8.4. Market Size and Forecast, By End User
    • 8.2.9. Mexico Genomics Market
      • 8.2.9.1. Market Size and Forecast, By Product
      • 8.2.9.2. Market Size and Forecast, By Technology
      • 8.2.9.3. Market Size and Forecast, By Application
      • 8.2.9.4. Market Size and Forecast, By End User
  • 8.3. Europe
    • 8.3.1. Key Market Trends and Opportunities
    • 8.3.2. Market Size and Forecast, By Product
    • 8.3.3. Market Size and Forecast, By Technology
    • 8.3.4. Market Size and Forecast, By Application
    • 8.3.5. Market Size and Forecast, By End User
    • 8.3.6. Market Size and Forecast, By Country
    • 8.3.7. France Genomics Market
      • 8.3.7.1. Market Size and Forecast, By Product
      • 8.3.7.2. Market Size and Forecast, By Technology
      • 8.3.7.3. Market Size and Forecast, By Application
      • 8.3.7.4. Market Size and Forecast, By End User
    • 8.3.8. Germany Genomics Market
      • 8.3.8.1. Market Size and Forecast, By Product
      • 8.3.8.2. Market Size and Forecast, By Technology
      • 8.3.8.3. Market Size and Forecast, By Application
      • 8.3.8.4. Market Size and Forecast, By End User
    • 8.3.9. Italy Genomics Market
      • 8.3.9.1. Market Size and Forecast, By Product
      • 8.3.9.2. Market Size and Forecast, By Technology
      • 8.3.9.3. Market Size and Forecast, By Application
      • 8.3.9.4. Market Size and Forecast, By End User
    • 8.3.10. Spain Genomics Market
      • 8.3.10.1. Market Size and Forecast, By Product
      • 8.3.10.2. Market Size and Forecast, By Technology
      • 8.3.10.3. Market Size and Forecast, By Application
      • 8.3.10.4. Market Size and Forecast, By End User
    • 8.3.11. UK Genomics Market
      • 8.3.11.1. Market Size and Forecast, By Product
      • 8.3.11.2. Market Size and Forecast, By Technology
      • 8.3.11.3. Market Size and Forecast, By Application
      • 8.3.11.4. Market Size and Forecast, By End User
    • 8.3.12. Rest of Europe Genomics Market
      • 8.3.12.1. Market Size and Forecast, By Product
      • 8.3.12.2. Market Size and Forecast, By Technology
      • 8.3.12.3. Market Size and Forecast, By Application
      • 8.3.12.4. Market Size and Forecast, By End User
  • 8.4. Asia-Pacific
    • 8.4.1. Key Market Trends and Opportunities
    • 8.4.2. Market Size and Forecast, By Product
    • 8.4.3. Market Size and Forecast, By Technology
    • 8.4.4. Market Size and Forecast, By Application
    • 8.4.5. Market Size and Forecast, By End User
    • 8.4.6. Market Size and Forecast, By Country
    • 8.4.7. China Genomics Market
      • 8.4.7.1. Market Size and Forecast, By Product
      • 8.4.7.2. Market Size and Forecast, By Technology
      • 8.4.7.3. Market Size and Forecast, By Application
      • 8.4.7.4. Market Size and Forecast, By End User
    • 8.4.8. Japan Genomics Market
      • 8.4.8.1. Market Size and Forecast, By Product
      • 8.4.8.2. Market Size and Forecast, By Technology
      • 8.4.8.3. Market Size and Forecast, By Application
      • 8.4.8.4. Market Size and Forecast, By End User
    • 8.4.9. India Genomics Market
      • 8.4.9.1. Market Size and Forecast, By Product
      • 8.4.9.2. Market Size and Forecast, By Technology
      • 8.4.9.3. Market Size and Forecast, By Application
      • 8.4.9.4. Market Size and Forecast, By End User
    • 8.4.10. South Korea Genomics Market
      • 8.4.10.1. Market Size and Forecast, By Product
      • 8.4.10.2. Market Size and Forecast, By Technology
      • 8.4.10.3. Market Size and Forecast, By Application
      • 8.4.10.4. Market Size and Forecast, By End User
    • 8.4.11. Australia Genomics Market
      • 8.4.11.1. Market Size and Forecast, By Product
      • 8.4.11.2. Market Size and Forecast, By Technology
      • 8.4.11.3. Market Size and Forecast, By Application
      • 8.4.11.4. Market Size and Forecast, By End User
    • 8.4.12. Rest of Asia-Pacific Genomics Market
      • 8.4.12.1. Market Size and Forecast, By Product
      • 8.4.12.2. Market Size and Forecast, By Technology
      • 8.4.12.3. Market Size and Forecast, By Application
      • 8.4.12.4. Market Size and Forecast, By End User
  • 8.5. LAMEA
    • 8.5.1. Key Market Trends and Opportunities
    • 8.5.2. Market Size and Forecast, By Product
    • 8.5.3. Market Size and Forecast, By Technology
    • 8.5.4. Market Size and Forecast, By Application
    • 8.5.5. Market Size and Forecast, By End User
    • 8.5.6. Market Size and Forecast, By Country
    • 8.5.7. Brazil Genomics Market
      • 8.5.7.1. Market Size and Forecast, By Product
      • 8.5.7.2. Market Size and Forecast, By Technology
      • 8.5.7.3. Market Size and Forecast, By Application
      • 8.5.7.4. Market Size and Forecast, By End User
    • 8.5.8. South Africa Genomics Market
      • 8.5.8.1. Market Size and Forecast, By Product
      • 8.5.8.2. Market Size and Forecast, By Technology
      • 8.5.8.3. Market Size and Forecast, By Application
      • 8.5.8.4. Market Size and Forecast, By End User
    • 8.5.9. Saudi Arabia Genomics Market
      • 8.5.9.1. Market Size and Forecast, By Product
      • 8.5.9.2. Market Size and Forecast, By Technology
      • 8.5.9.3. Market Size and Forecast, By Application
      • 8.5.9.4. Market Size and Forecast, By End User
    • 8.5.10. UAE Genomics Market
      • 8.5.10.1. Market Size and Forecast, By Product
      • 8.5.10.2. Market Size and Forecast, By Technology
      • 8.5.10.3. Market Size and Forecast, By Application
      • 8.5.10.4. Market Size and Forecast, By End User
    • 8.5.11. Rest of LAMEA Genomics Market
      • 8.5.11.1. Market Size and Forecast, By Product
      • 8.5.11.2. Market Size and Forecast, By Technology
      • 8.5.11.3. Market Size and Forecast, By Application
      • 8.5.11.4. Market Size and Forecast, By End User

CHAPTER 9: COMPETITIVE LANDSCAPE

  • 9.1. Introduction
  • 9.2. Top Winning Strategies
  • 9.3. Product Mapping of Top 10 Player
  • 9.4. Competitive Dashboard
  • 9.5. Competitive Heatmap
  • 9.6. Top Player Positioning, 2023

CHAPTER 10: COMPANY PROFILES

  • 10.1. Color Genomics, Inc.
    • 10.1.1. Company Overview
    • 10.1.2. Key Executives
    • 10.1.3. Company Snapshot
    • 10.1.4. Operating Business Segments
    • 10.1.5. Product Portfolio
    • 10.1.6. Business Performance
    • 10.1.7. Key Strategic Moves and Developments
  • 10.2. BGI Genomics
    • 10.2.1. Company Overview
    • 10.2.2. Key Executives
    • 10.2.3. Company Snapshot
    • 10.2.4. Operating Business Segments
    • 10.2.5. Product Portfolio
    • 10.2.6. Business Performance
    • 10.2.7. Key Strategic Moves and Developments
  • 10.3. Agilent Technologies
    • 10.3.1. Company Overview
    • 10.3.2. Key Executives
    • 10.3.3. Company Snapshot
    • 10.3.4. Operating Business Segments
    • 10.3.5. Product Portfolio
    • 10.3.6. Business Performance
    • 10.3.7. Key Strategic Moves and Developments
  • 10.4. Danaher Corporation
    • 10.4.1. Company Overview
    • 10.4.2. Key Executives
    • 10.4.3. Company Snapshot
    • 10.4.4. Operating Business Segments
    • 10.4.5. Product Portfolio
    • 10.4.6. Business Performance
    • 10.4.7. Key Strategic Moves and Developments
  • 10.5. Eppendorf AG
    • 10.5.1. Company Overview
    • 10.5.2. Key Executives
    • 10.5.3. Company Snapshot
    • 10.5.4. Operating Business Segments
    • 10.5.5. Product Portfolio
    • 10.5.6. Business Performance
    • 10.5.7. Key Strategic Moves and Developments
  • 10.6. Eurofins Scientific SE
    • 10.6.1. Company Overview
    • 10.6.2. Key Executives
    • 10.6.3. Company Snapshot
    • 10.6.4. Operating Business Segments
    • 10.6.5. Product Portfolio
    • 10.6.6. Business Performance
    • 10.6.7. Key Strategic Moves and Developments
  • 10.7. F. Hoffmann-La Roche Ltd.
    • 10.7.1. Company Overview
    • 10.7.2. Key Executives
    • 10.7.3. Company Snapshot
    • 10.7.4. Operating Business Segments
    • 10.7.5. Product Portfolio
    • 10.7.6. Business Performance
    • 10.7.7. Key Strategic Moves and Developments
  • 10.8. GE Healthcare
    • 10.8.1. Company Overview
    • 10.8.2. Key Executives
    • 10.8.3. Company Snapshot
    • 10.8.4. Operating Business Segments
    • 10.8.5. Product Portfolio
    • 10.8.6. Business Performance
    • 10.8.7. Key Strategic Moves and Developments
  • 10.9. Illumina, Inc.
    • 10.9.1. Company Overview
    • 10.9.2. Key Executives
    • 10.9.3. Company Snapshot
    • 10.9.4. Operating Business Segments
    • 10.9.5. Product Portfolio
    • 10.9.6. Business Performance
    • 10.9.7. Key Strategic Moves and Developments
  • 10.10. Bio-Rad Laboratories, Inc.
    • 10.10.1. Company Overview
    • 10.10.2. Key Executives
    • 10.10.3. Company Snapshot
    • 10.10.4. Operating Business Segments
    • 10.10.5. Product Portfolio
    • 10.10.6. Business Performance
    • 10.10.7. Key Strategic Moves and Developments